Revenue: The sum of all revenue fields included for a company's operating activities.
Caribou Biosciences, Inc. (CRBU) had Revenue of $2.35M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$2.35M |
$-39.99M |
|
-- |
|
$2.35M |
|
$45.27M |
|
$-42.91M |
|
$2.92M |
|
$-39.99M |
|
$-39.99M |
|
$-39.99M |
|
$-39.99M |
|
$-39.99M |
|
$-39.99M |
|
$-42.91M |
|
$-42.20M |
|
92.68M |
|
92.68M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$217.32M |
|
$18.52M |
|
$56.33M |
|
$273.66M |
|
$28.49M |
|
-- |
|
$27.94M |
|
$56.43M |
|
$217.22M |
|
$217.22M |
|
$217.22M |
|
93.00M |
|
| Cash Flow Statement Financials | |
$-36.73M |
|
$49.38M |
|
$0.47M |
|
$16.34M |
|
$29.46M |
|
$13.12M |
|
$3.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1823.76% |
|
-1823.76% |
|
-- |
|
-1699.58% |
|
-1699.58% |
|
$-37.77M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.22 |
|
73.90 |
|
-18.41% |
|
-18.41% |
|
-14.61% |
|
-18.41% |
|
$2.34 |
|
$-0.41 |
|
$-0.40 |
|